Tofacitinib can decrease anti-DNA antibody titers in inactive systemic lupus erythematosus complicated by rheumatoid arthritis
- 3 August 2015
- journal article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 26 (4), 633-634
- https://doi.org/10.3109/14397595.2015.1069473
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Tofacitinib versus Methotrexate in Rheumatoid ArthritisThe New England Journal of Medicine, 2014
- Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic studyArthritis & Rheumatism, 2013
- Taming lupus—a new understanding of pathogenesis is leading to clinical advancesNature Medicine, 2012
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982